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doi:10.1016/j.jmii.2011.04.009Mycobacterium avium subsp paratuberculosis (MAP), excreted in the feces and milk, is re-
ported to be not easily inactivated by pasteurization and thermal treatments as other bacteria
infecting humans and animals do. The D values of all MAP strains tested were considerably
higher than those published for other pathogens. Culturing techniques for this organism are
labor intensive. Although an increasing amount of scientific evidence suggests that this
organism can be responsible for at least some cases of Crohn’s disease (CD), there is contro-
versy about MAP being a cause of CD in humans. In general, although some studies have
described an association between the presence of MAP and CD, the role of Mycobacterium
species and MAP in the etiology of this human disease remains unestablished. Although pub-
lished reports indicate that it may not be completely inactivated by pasteurization of milk,
the effectiveness of increasing the time or temperature in the pasteurization process has
not been established and hence any potential benefit to human health cannot be determined.
This article summarizes the incidences of MAP in milk and milk products with respect to human
health and brief discussion of various serological as well as molecular techniques used for their
isolation, enumeration, and characterization.
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Mycobacterium avium subsp paratuberculosis (MAP) is the
etiologic agent of paratuberculosis, a disease with consid-
erable economic impact, principally on dairy cattle herds.62
MAP have been also causing considerable concern to the
dairy industry worldwide in recent years because of unre-
solved issue of its potential role in Crohn’s disease (CD) in
humans.28,33,46 Published reports indicate that it may not
be completely inactivated by pasteurization of milk at 72C
for 15 seconds.28,68 Determination of definitive thermal
destruction characteristics of MAP does not represent
a trivial undertaking because culturing technique of this
organism is labor intensive and very slow, taking up to 16
weeks to produce visible colonies on appropriate microbi-
ological media.20,29
Morphologically, they are gram positive, aerobic plump
big rods, having 1e2 mm length, and having an acid-fast
nature.35 The property of acid fastness is because of waxy
materials in the cell walls and it is particularly important for
recognizing them. MAP is an obligate intracellular path-
ogen; it lacks the iron-chelating compound mycobactin, and
thus they can only survive in a host that can provide the iron
required for growth.23 It is closely related to other M avium
bacteria, sharing some antigenic determinants and differ-
entiated from the other mycobacterial species, which are
common in the environment by its ability to cause bowel
disease in cattle and other animal species.6,17 It is found
that anti-M bovis antibodies generated the cross-reaction
to MAP. There is a paucity of information in relation to
MAP in milk and milk products. This article encompasses the
scientific literature relating to disease, diagnosis, effect of
processing, detection, and enumeration of concerned
organism under laboratory conditions.
Disease in animal
Paratuberculosis, commonly known as Johne’s disease (JD),
is caused by MAP in cattle and in other ruminants, such as
goat, sheep, deer, elk, antelope, and camelids, whereas
guinea pigs, rabbits, rats, and mice are not affected by
MAP.27,39,47 It is a transmissible disease and the infection
may be chronic, progressive, and incurable. Typical signs
are rapid weight loss, diarrhea that lasts for more than 3
days, and failure to respond medical treatment. Cattle with
JD do not have a fever, continue to eat, and generally
appear to feel well. As the infection progresses, excretion
of MAP in feces and milk occurs. Infection of newborn
calves occurs by ingestion of milk from infected cows.
Typically, cattle develop clinical signs between 3 and 5
years of age that progress over a 3e6 months period. Small
ruminant species, such as sheep and goat, generally do not
exhibit diarrhea, although the feces may be less formed
than normal. The progression of disease is generally more
rapid in these species than in cattle, with weight loss being
the predominant sign.74 In addition to the classic clinical
signs attributed to JD, other secondary clinical effects have
been reported in dairy cattle. Decreased milk production is
considered a major economic consequence of this infection
and has been documented for both subclinical and clinical
MAP infection.3,75 Increased mortality rates have beenidentified in infected dairy herds,57,60 whereas other
reports have identified reduced reproductive performance
in infected cows.61 Several anecdotal reports suggest that
MAP infection may predispose cows to the development of
mastitis; however, in one epidemiologic study, MAP infec-
tion was associated with decreased incidence of mastitis.75
Clinically affected animals shed as many as 5 1012 MAP
cells per day in feces10,11 and they can remain viable for
several months in the environment. They have been also
isolated from colostrums of subclinically infected cows.67
Consequently, raw products originating from cattle may
harbor MAP.66
Disease in humans
CD is a painful, chronic, often debilitating, inflammatory
disease of the gastrointestinal tract that affects at least
500,000 Americans and millions more worldwide. Incidence
of CD is increasing in developed countries.1,43,49 Genetic
and environmental factors seem to be involved in the
etiology of CD as well as immune disregulation. CD is
probably a multifactorial disease because although envi-
ronmental factors (as infection or diet) and at least eight
genetic loci have been implicated, none of them have been
proven to cause the disease alone.2,5 The fact that MAP can
cause disease in several mammal species, including
primates, is an argument in favor of the link between MAP
and CD in humans.9,11 Similarities between CD and JD point
to a possible link to MAP infection.
The area first affected in the patient is the lymph nodes
of the neck, which clearly indicates that the obvious route
for the entry of pathogen-MAP is the mouth, that is, through
consumption of MAP contaminated food. MAP in human
assumes an obligate intracellular spheroplast form, residing
in macrophages and dendritic cells, as other mycobacteria.
Production of proinflammatory cytokines by MAP infected
cells of susceptible host may contribute to generate the
inflammatory process in CD.2,9 The disease is autoimmune,
causes immune system to attack, and inflame the body’s
own tissues of the gastrointestinal tract and also in other
parts of the body.59,71
The association between MAP and human’s CD is highly
controversial.4,50,55 In 1984, Chiodini et al7 reported the
first isolation of this organism from a CD patient. Further
studies showed that these isolates were able to cause JD by
oral inoculation in goats.26,72Since then a variety of studies
have been conducted to determine whether there is
a correlation between the presence of MAP or other
mycobacterium species and human CD. Many studies have
shown that a variety of mycobacterium species, including
MAP, can be isolated from patients with CD. For example,
Chiodini et al8 isolated MAP from two of four patients with
CD but from none of 26 controls samples. Although Sand-
erson et al58 found that 65% of the intestinal samples from
the CD patients (nZ 40) tested positive for the presence of
MAP DNA by polymerase chain reaction (PCR) as compared
with 10% of the samples from controls (no inflammatory
bowel disease or ulcerative colitis; nZ 63), Fidler et al25
reported that 4 of 31 CD tissues, but none of 30 control
and ulcerative colitis derives samples, were positive for
MAP DNA by PCR. Additional studies also found a higher
Mycobacterium avium subsp. paratuberculosis in human health 475incidence of MAP DNA in tissues from CD patients as
compared with control samples.19 However, other studies
did not find any evidence for the presence of mycobacterial
DNA in tissues from CD patients using PCR.57,76 MAP was
detected by PCR and culture from intestinal tissue, blood,
and breast milk of CD patients.4,50,51 Recently, a report
showed that administration of MAP to interleukin-10-defi-
cient mice housed in a germfree environment led to colitis
development; increase in serum tumor necrosis alpha,
interferon gamma, and chemokines; and also an increase in
lymphocyte proliferation and interleukin-2 production.61
However, to enable consumer assurance of the microbial
safety of their pasteurized dairy products, determination of
thermal destruction characteristics of MAP is a very high
priority for the dairy industry.
Milk and MAP
According to a study conducted by the United States
Department of Agriculture in 1996, in the United States,
between 20% and 40% of dairy cattle herds are infected
with MAP, resulting in economic losses of at least US$1.5
billion each and every year.6 Collins15 stated that MAP
affects approximately 33% of US dairy herds and dramati-
cally reduces milk production, reproductive performance,
and animal condition66 and thus has a significant negative
economical impact on the dairy industry. The herd preva-
lence of MAP infection in Western Europe and North
America is reported to be in the range 21e70%.3 These
subclinically infected animals shed MAP in their milk and
onto pastures.36 It has been suggested that MAP-infected
macrophages are present in lipid droplets on the cream
layer of milk.41 The mechanism of the shedding of MAP
organisms into milk has not yet been well investigated.
Presumably, the shedding of MAP into milk occurs by
hematogenous or lymphatic spread.
Many researches have shown that milk-producing cows
affected by JD may pass MAP into the milk.26,31 If the
animals show physical signs of JD, the milk is thrown away,
but some animals can carry MAP without showing any sign.
The milk from these animals goes into the general milk
supply for pasteurization. MAP has also been detected in
retail cheeses in the United States, the Czech Republic, and
Greece by culture and PCR methods.62
There is a body of opinion which holds that although the
incomplete inactivation of the bacteria by pasteurization,
under laboratory conditions, results from clumping, which
effectively protects at least some of the organisms from the
full effects of the heat applied, the relative turbulence of
the flow of milk through commercial pasteurizers prevents
clumping and thus allows for a higher kill. This, coupled
with the much lower burden of bacteria resulting from the
dilution effect of bulking milk from a large number of cows,
is one of the bases for an optimistic view of the risk
involved.31
Effect of processing
MAP is affected by physical factors like processing and
storage temperature, radiation treatment, and so on, as
well as by some of the chemical and environmental factors,such as, NaCl, NaOH, and pH.7,29,69 Currently, the most
common method for destroying pathogenic microorganisms
and for reducing or eliminating spoilage organisms in
various dairy products is through pasteurization by high
temperature short time (HTST) method that was introduced
in the mid-19th century as a public health measure to
destroy the most heat-resistant nonspore-forming human
pathogens, such as M tuberculosis and Coxiella burnetti,
that are likely to be present in raw milk.35,38
There are many evidences that indicate that MAP is not
killed by the standard food processing techniques, such as
cooking and pasteurization, that we rely on to protect
ourselves from disease causing bacteria.7,29,68 In one study
to examine commercially pasteurized milk for the presence
of MAP, Millar et al46 found that at least 15 of 312 milk
samples collected at retail stores contained viable MAP.
These results do not necessarily prove that MAP survives
commercial pasteurization procedures but could also
suggest the possibility of postpasteurization contamination
with this organism. Studies by Grant et al32 suggested that
homogenization increases the lethality of subsequent heat
treatment to some extent with respect to MAP, but the
extended 25-seconds holding time at 73C was found to
be no more effective at killing MAP than the standard
15-seconds holding time. This provides clear evidence that
MAP bacteria in naturally infected milk are capable of
surviving commercial HTST pasteurization if they are
present in raw milk in sufficient numbers.
In one of the study, Grant et al28 isolated MAP from milk
samples (12 of 27) after heat treatment at 72.5C, that is, a
temperature close to the minimum pasteurization
temperature specified by the legislation or from non-
homogenized milk (13 of 27). It has been shown that viable
MAP can be detected even after application of different
levels of pressure in conjunction with pasteurization.20 The
survival of cells in clusters after pasteurization has been
confirmed by the several studies.35,40 Heat treatment with
concurrent homogenization applied either as a separate
process or in the dwell zone resulted in a significantly lower
number of positive samples than pasteurization without
homogenization.28 Sung and Collins69 found that MAP can
survive in cheese (2% salt, pH 5.0). They also stated that
MAP may survive HTST pasteurization when the initial
organism concentration is greater than 101 cells/mL. The D
values of all MAP strains tested were considerably higher
than those published for Listeria (71.7C/5 sec) and Cox-
iella sp (62C/30 min) and estimated for M bovis (71.5C/14
sec), indicating that MAP is more thermally tolerant and far
most resistant to inactivation by low pH, such as 4.0.31,69
According to UK Food Standards Agency, D values for MAP
cited within most of the industry is found to be ranged
between 71/72C for 12e14 seconds. Collins et al14 found
that when 1e4% NaOH solution is mixed with suspension of
MAP in water, 1% NaOH caused more than 2log10 decrease in
viable MAP within 15 minutes contact and concentration
where as, 2% causes total killing of MAP in less than 60
seconds. However, some workers found that MAP got inac-
tivated at laboratory scale pasteurization of milk.37,66
According to Richards and Theon,56 bovine fecal samples
infected naturally and experimentally showed significantly
decreased viable MAP counts when stored at 70C after
3 weeks. Continued refrigeration up to 15 weeks did not
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cells were suspended in sterile deionized water 4 mW-s/
cm2, UV radiation is sufficient to achieve a 1 log10 reduction
in total viable count, and at UV doses greater than 15 mW-
s/cm2, complete disinfection is achieved.14 However,
recent work in Australia indicates that UV light had minimal
effect on MAP viability in spiked soil.45 A study on irradia-
tion of MAP suspended in bovine colostrums, however,
found that if frozen bovine colostrums spiked with 104 MAP/
mL is exposed to 10 kGy gamma radiation, 100% of the
organisms are killed.43
Isolation of MAP from milk
The lack of an appropriate selective culture medium, the
organism’s slow growth rate compared with other milk
microorganisms, and the low numbers of MAP in milk may
significantly posses a number of difficulties in isolation of
MAP either from milk or from other related products.20 The
successful isolation of MAP from a food or clinical spec-
imen, as for other Mycobacterium sp, is currently reliant on
chemical decontamination of the sample to inactivate
undesirable microorganisms that could overgrow the slow-
growing MAP cells during subsequent culture. A range of
decontamination procedures have been used by different
researchers.16,46,70 Most decontaminants are bacteriostatic
for MAP at low concentration and become bactericidal at
higher concentration when kept in contact with the sample
for longer time periods.70
Test sensitivity is a key consideration where the isolation
of MAP from milk is concerned and it must be realized that
decontamination protocols developed for the isolation of
MAP from feces may not be appropriate for milk.11,70
Because MAP are likely to be present in the feces of an
infected cow with JD in much higher numbers [108 colony
forming unit (CFU)/g] than are thought to occur in milk
(2e8 CFU/50 mL). Such milk is aseptically obtained from
infected cows.
Dundee et al21 concluded that the decontamination
protocol involving 0.75% (wt/vol) hexadecylpyridinium
chloride for 5 hours at room temperature was the most
sensitive for the recovery of MAP from liquid milk, although
a decontamination step used to isolate MAP from cheese or
other dairy products may sometime have implications for the
accurate enumeration of MAP. For an example, Spahr and
Schafroth64 reported a loss of 60% in the colony forming units
of MAP in decontaminated Swiss cheese samples compared
with nondecontaminated samples. Therefore, monitoring
the persistence of MAP in cheese may rely on culture
methods without prior decontamination of the sample.
Decontamination step is usually followed by culturing of
MAP on selective media. A range of solid and liquid culture
media, with a variety of appropriate supplements, are
being used for the culture of MAP from dairy products,
including Herrold’s egg yolk medium (solid), BACTEC
radiometric medium (liquid), Dubos broth (liquid), and
modified Middlebrook agar (solid).21 Selectivity of these
media has been improved by the incorporation of antibiotic
mixtures, including polymyxin, amphotericin B, nalidixic
acid, trimethoprim, and azlocillin.20 Irrespective of the
medium used, the plates are required to be incubated at37C for up to 18 weeks for the proper development of MAP
colonies.29
Detection methods for MAP
Because of fastidious growth pattern of the microorganism
and paradoxical immune response of the host animal to
infection, diagnosis of this organism is very difficult.
Detection and enumeration of MAP from milk and other
infected matter is possible using various serological and
molecular techniques or combination of thereof. In that,
the major serological tests includes radioimmunoassay,
enzyme-linked immunosorbent assay (ELISA), agar gel
immunodiffusion (AGID), and complement fixation (CF),
and so on, which are easy to perform but at the same time
not much sensitive,12,42,60 whereas PCR, nucleic acid
hybridization using probes, immunomagnetic separation
(IMS), radiometric detection, and flow cytometry (FCM) are
the widely used recent methods for the detection of MAP
from contaminated materials.
Generally, it is very difficult to compare the sensitivities
or specificities from different serological tests using
different samples or carrying out different conditions.
Different authors had reported higher specificities for
different serologic tests using same grouped specimens,
such as Sherman et al,60 97.4% for CF and 99.4% for AGID;
Sockett et al,63 95.4% and 99% for two ELISA, 99% for CF and
100% for AGID. AGID represents an easy-performing and
low-cost method; but because of its low sensitivity rate, it
has shown to be unsatisfactory as a screening diagnostic
method for subclinical herd infections.24 Nevertheless,
because it presented an acceptable specificity rate, it can
be useful as a confirmatory diagnosis method of clinical
disease suspect animals. CF is the official test in many
countries for cattle. As cross reactions with other bacteria
have been reported for this test in cattle, it is no longer
considered sufficiently accurate for diagnostic purposes. In
brief, a consistent, standardized, and quality-controlled
serological test for evaluating same grouped specimens
would be useful to discuss the advantages or disadvantages
among different serological tests.
Malamo et al44 developed modification of ELISA to
detect antibodies specific to truncated 34 kDa proteins of
MAP. The 34-kDa protein of MAP is immunodominant; and at
the carboxyl terminus, it is reported to contain specific
epitopes for MAP and therefore the method showed high
specificity and sensitivity. Similarly Speer et al,65 used
formaldehyde and sonication with ELISA, so called SELISA
and found that SELISAs prepared by treating MAP with 37%
formaldehyde and then a 2-seconds burst of sonication
produced the greatest difference (7) between MAP-
negative and MAP-positive serum samples. They
concluded that the diagnostic sensitivity and specificity for
JD by the SELISA were greater than 95%; and based on
diagnostic sensitivity as well as specificity, the SELISA
appears superior to the commercial ELISAs routinely used
for the diagnosis of JD. Eda et al22 compared results of the
FCM with that of a commercially available ELISA and found
that serum samples which had tested negative by ELISA
were also found to be JD-positive by FCM. The probable
reason may be that FCM is based on detection of DNA/RNA
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ELISA. The FCM is capable of distinguishing MAP-infected
from MAP-noninfected cattle as well as MAP from M scrof-
ulaceum and M avium subsp avium.
In IMS technique, rabbit polyclonal antibodies against
radiation-killed intact MAP cells are required to coat sheep
anti-rabbit IgG type M-280 Dynabeads, also known as
immunomagnetic beads (IMB). The IMB were found to have
a maximum binding capacity of 104e105 CFU of MAP. Grant
et al30 found that IMS technique selectively recovered MAP
from inoculated milk containing as few as 10 CFU of MAP
per milliliter when 10 mL of IMB (ca. 106 beads) was added
to 1 mL of milk after incubation. Collins et al13 in one
experiment compared the radiometric technique with
conventional methods and found that out of 75 positive
specimens; the radiometric technique detected 92%,
whereas conventional methods detected 60%. It suggests
that radiometric detection method is useful tool for diag-
nosis and control of bovine paratuberculosis.
PCR makes it possible to detect small number of MAP
against background of other DNA signals of human origin
present in the sample. It is developed on the basis of
detection of insertion sequence 900 (IS900) of MAP in raw
milk.52,54 The insertion sequence IS900 appears to be found
only in MAP and about 15e20 dispersed copies of IS900
sequence are integrated into genome of MAP in a stable
manner.34,52,73 According to Pillai and Jayarao,53 detection
of MAP by IS900 PCR was found to be consistent (24/24 PCR
assays) when about 100 CFU/mL were present, whereas
detection was variable (12/24 PCR assays) at concentra-
tions as low as 10 CFU/mL. The results of their study also
suggested that MAP can be detected directly from quarter
milk and bulk tank milk by IS900 PCR. However, sensitivity
regarding low number of these organisms in milk samples
could affect the results of IS900 PCR.
Preparation of nucleic acid probe requires the identifi-
cation of a species-specific DNA segment, which is then
cloned and possibly sequenced. Only two species-specific
DNA fragments have been identified in the MAP genome.
One probe corresponds to a part of the IS900 sequence and
it was claimed to identify the DNA from 102 cells after
amplification by PCR. The other probe F57 that is 620 base
pairs long and able to recognize all of the tested MAP
strains is isolated from paratuberculous animals and
humans with CD.47,48,52 The potential value of IMS method
is as an aid for rapid detection of MAP in milk when it is used
in conjunction with end point detection methods, such as
IS900 PCR or an ELISA.
Del Prete et al18 carried out detection of MAP in stool
samples of patients with inflammatory bowel disease using
IS900-based PCR followed by identification involving
a colorimetric detection procedure designed DNA enzyme
immunoassay, based on the hybridization of the denatured
DNA with a nonradioactively labeled interprimer-specific
oligonucleotide probe. They suggested that newly devel-
oped PCR-DNA enzyme immunoassay technique have
a higher sensitivity than cultural technique and being much
more rapid, representing a useful tool for both epidemio-
logical and therapeutic purposes.
It is reasonable to prohibit the use of milk derived from
animals with clinical JD in the interim between their
identification and their removal from the herd because theuse of milk from such animals for calves is likely to facili-
tate spread of infection and prohibition of its use for this
purpose may also be reasonable. Because culturing tech-
niques used for the detection of MAP is time consuming,
newly developed serological or molecular methods may
provide better alternative because they reveal higher
sensitivity than cultural technique and being much more
rapid, representing a useful tool for both epidemiological
and therapeutic purposes. Although we know that MAP may
pass into the human food chain via cows’ milk, we do not
know if the bacteria contribute to CD in humans, although
it has been reported that MAP has been detected more
commonly in patients with CD than in the general pop-
ulation. Normal pasteurization of milk at 71.7C for 15
seconds kills low levels of MAP; however, experimental
work in laboratory conditions has shown that at high levels
of MAP, normal pasteurization does not render all of the
bacteria nonviable. The effectiveness of increasing the
time or temperature in the pasteurization process has not
been established and hence any potential benefit to human
health cannot be determined.
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